Cch1p Mediates Ca2+ Influx to Protect Saccharomyces cerevisiae against Eugenol Toxicity

Eugenol has antifungal activity and is recognised as having therapeutic potential. However, little is known of the cellular basis of its antifungal activity and a better understanding of eugenol tolerance should lead to better exploitation of eugenol in antifungal therapies. The model yeast, Saccharomyces cerevisiae, expressing apoaequorin was used to show that eugenol induces cytosolic Ca²⁺ elevations. We investigated the eugenol Ca²⁺ signature in further detail and show that exponentially growing cells exhibit Ca²⁺ elevation resulting exclusively from the influx of Ca²⁺ across the plasma membrane whereas in stationary growth phase cells Ca²⁺ influx from intracellular and extracellular sources contribute to the eugenol-induced Ca²⁺ elevation. Ca²⁺ channel deletion yeast mutants were used to identify the pathways mediating Ca²⁺ influx; intracellular Ca²⁺ release was mediated by the vacuolar Ca²⁺ channel, Yvc1p, whereas the Ca²⁺ influx across the plasma membrane could be resolved into Cch1p-dependent and Cch1p-independent pathways. We show that the growth of yeast devoid the plasma membrane Ca²⁺ channel, Cch1p, was hypersensitive to eugenol and that this correlated with reduced Ca²⁺ elevations. Taken together, these results indicate that a cch1p-mediated Ca²⁺ influx is part of an intracellular signal which protects against eugenol toxicity. This study provides fresh insight into the mechanisms employed by fungi to tolerate eugenol toxicity which should lead to better exploitation of eugenol in antifungal therapies.